Literature DB >> 19966347

Initial presentation and management of osteosarcoma, and its impact on disease outcome.

Janet Y K Yang1, Frankie W T Cheng, K C Wong, Vincent Lee, W K Leung, Matthew M K Shing, Shekhar M Kumta, C K Li.   

Abstract

OBJECTIVE: To evaluate the initial presenting symptoms and management of osteosarcoma in Hong Kong Chinese children, in relation to any possible impact on disease outcomes.
DESIGN: Retrospective study.
SETTING: A tertiary referral centre of bone cancer in a university teaching hospital in Hong Kong. PATIENTS: All children aged younger than 18 years with a diagnosis of osteosarcoma who received treatment from March 1994 to October 2005.
RESULTS: A total of 51 children were studied. The median age of onset was 13 (range, 3-20) years; 61% were males. The tumours were located in the distal femur and proximal tibia, which accounted for 45% and 22% of the cases, respectively; 24% of patients had metastatic disease at presentation. Swelling (76%) and pain (90%) were the most common presenting complaints. Approximately one third of the patients had a preceding history of trauma. The median duration of initial symptoms to first medical consultation of any sort was 30 (range, 0-360) days. The median time from the first consultation to a definitive diagnosis was 21 (range, 0-350) days; 25% were diagnosed more than 52 days after presentation. Bonesetters were initially consulted by 37% of these patients. From presentation to diagnosis, the median duration was 61 (range, 4-361) days. Analysis of the duration of pre-diagnosis symptoms did not correlate significantly with the development of metastatic disease, response to chemotherapy, feasibility of limb salvage surgery, relapse rates, or survival rates.
CONCLUSIONS: In Hong Kong, initial consultation to bonesetters was common. A relatively long delay in between symptom onset and diagnosis of osteosarcoma was encountered. The public and medical practitioners should be made aware of this disease, especially in adolescents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19966347

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  8 in total

1.  One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation.

Authors:  R Nandra; N Hwang; G S Matharu; K Reddy; R Grimer
Journal:  Ann R Coll Surg Engl       Date:  2015-08-14       Impact factor: 1.891

2.  Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison.

Authors:  Tracy A Marko; Brandon J Diessner; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2016-02-29       Impact factor: 3.167

3.  An Evidence-Based Case Study of Unilateral Shin Splints: Do Red Flags Function in Paediatric Osteosarcoma?

Authors:  Anne Rankin
Journal:  Physiother Can       Date:  2015       Impact factor: 1.037

4.  Identification and validation of microRNAs and their targets expressed in osteosarcoma.

Authors:  Can Zhang; Jun Wan; Feng Long; Qing Liu; Hongbo He
Journal:  Oncol Lett       Date:  2019-09-13       Impact factor: 2.967

Review 5.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

6.  The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes.

Authors:  Vicky Soomers; Olga Husson; Robin Young; Ingrid Desar; Winette Van der Graaf
Journal:  ESMO Open       Date:  2020-02

7.  Delay in diagnosis of primary osteosarcoma of bone in children: Have we improved in the last 15 years and what is the impact of delay on diagnosis?

Authors:  Shinichirou Yoshida; James Celaire; Chloe Pace; Charles Taylor; Yoichi Kaneuchi; Scott Evans; Adesegun Abudu
Journal:  J Bone Oncol       Date:  2021-03-29       Impact factor: 4.072

8.  Symptom Interval in Cases of Benign Cystic Lesions of Bone and its correlation with Surgical Intervention.

Authors:  Aakriti Jain; Sitanshu Barik; Roop Bhushan Kalia; Shobha S Arora; Nikhil Goyal
Journal:  Indian J Orthop       Date:  2020-05-29       Impact factor: 1.251

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.